Optimization of In-Situ Exosome Enrichment Methodology On-a-Chip to Mimic Tumor Microenvironment Induces Cancer Stemness in Glioblastoma Tumor Model
Cells · 2025
DOI: 10.3390/cells14090676 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Saleheh Saffar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran. Hauptthemen laut MEDLINE: Glioblastoma, Tumor Microenvironment, Exosomes, Neoplastic Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Understanding cancer etiology requires replicating the tumor microenvironment (TME), which significantly differs from standard in vitro cultures due to nutrient limitations, acidic pH, and oxidative stress. To address this, a microfluidic bioreactor (µBR) with an expanded culture surface was designed to optimize exosome enrichment and glioblastoma cell behavior. Using response surface methodology (RSM), key parameters—including medium exchange volume and interval time—were optimized, leading to about a six-fold increase in exosome concentration without artificial inducers. Characterization techniques (SEM, AFM, DLS, RT-qPCR, and ELISA) confirmed significant alterations in exosome profiles, cancer stemness, and epithelial-mesenchymal transition (EMT)-related markers. Notably, EMT was induced in the µBR system, with a six-fold increase in HIF-1α protein despite normoxic conditions, suggesting activation of compensatory signaling pathways. Molecular analysis showed upregulation of SOX2, OCT4, and Notch1, with SOX2 protein reaching 28 ng/mL, while it was undetectable in traditional culture. Notch1 concentration tripled in the µBR system, correlating with enhanced stemness and phenotypic heterogeneity. Immunofluorescent microscopy confirmed nuclear SOX2 accumulation and co-expression of SOX2 and HIF-1α in dedifferentiated CSC-like cells, demonstrating tumor heterogeneity. These findings highlight the µBR’s ability to enhance stemness and mimic glioblastoma’s aggressive phenotype, establishing it as a valuable platform for tumor modeling and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran.
- Department of Chemistry, Michigan State University, East Lansing, MI 48824-1322, USA.
- Institute for Stem Cell Research and Regenerative Medicine, Tehran University of Medical Sciences, Tehran 1419733151, Iran.
- Department of Anatomical Sciences, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 1411713116, Iran.
- Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran 1419733151, Iran.
ORCID-Profile: Saleheh Saffar, Ali Ghiaseddin, Shiva Irani
Zitieren
APA
Saffar, S., Ghiaseddin, A., Irani, S., & Hamidieh, A. A. (2025). Optimization of In-Situ Exosome Enrichment Methodology On-a-Chip to Mimic Tumor Microenvironment Induces Cancer Stemness in Glioblastoma Tumor Model. Cells. https://doi.org/10.3390/cells14090676
Vancouver
Saffar S, Ghiaseddin A, Irani S, Hamidieh AA. Optimization of In-Situ Exosome Enrichment Methodology On-a-Chip to Mimic Tumor Microenvironment Induces Cancer Stemness in Glioblastoma Tumor Model. Cells. 2025. doi:10.3390/cells14090676
BibTeX
@article{Saffar2025,
author = {Saffar, Saleheh and Ghiaseddin, Ali and Irani, Shiva and Hamidieh, Amir Ali},
title = {Optimization of In-Situ Exosome Enrichment Methodology On-a-Chip to Mimic Tumor Microenvironment Induces Cancer Stemness in Glioblastoma Tumor Model},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14090676}
}
EUVIMED